◆ NeutralTTDOPRXMGNIPUBM

Will OPRX's OpenPath Deal Help TTD Capture More Healthcare Ad Dollars?

Zacks Investment Research·
Will OPRX's OpenPath Deal Help TTD Capture More Healthcare Ad Dollars?

The Trade Desk (TTD) is strengthening its healthcare advertising position through a new integration with OptimizeRx (OPRX), giving advertisers access to authenticated healthcare professional inventory across 400+ EHR systems reaching ~800,000 verified HCPs. The inventory will be available via TTD's OpenPath platform in Q4 2026. This partnership complements TTD's recent expansions with Veeva Crossix and IQVIA Digital, potentially attracting more pharma and life sciences advertisers. However, TTD shares have declined 71.9% over the past year and carry a Zacks Rank #4 (Sell) rating.

Read Full Article at Zacks Investment Research
← Back to Financial Intelligence